CanSino gets China nod for inhaled COVID-19 vaccine trial

China's CanSino Biologics Inc said on Monday it won approval for a clinical trial in the country to develop an inhaled version of its COVID-19 vaccine.

from Latest News https://ift.tt/2P1FqCO